NET-RARE third workshop third workshop focuses on the latest technologies for identifying new biomarkers to enable early detection and better characterization of rare diseases. It also aims to explore strategies for … Read more
IBEC researcher Juanma Fernández recently has received funding from the French AFM-Telethon to carry out the project “Monitoring of fibrotic processes in 3D skeletal muscle co-cultures for Muscular Dystrophies using plasmonic biosensors”. The objective is to develop multiplexing sensor devices to achieve online, real-time sensing capability to monitor fibrosis markers and evaluate drug response in muscular dystrophy in vitro models.
Ref: RT_XT // Deadline: 15/08/2025
Ref: PD1-MS // Deadline: 10/09/2025
Ref: RT_JR // Deadline: 15/08/2025
Ref: PHD-IM2 // Deadline: 05/10/2025
The IBEC Code of Conduct for Research Integrity (the Code) is one of the actions within the framework of the Human Resources Strategy for Researchers (HRS4R) according to the European … Read more
Researchers at the Institute for Bioengineering of Catalonia (IBEC) have created the world’s simplest artificial cell capable of chemical navigation, migrating toward specific substances like living cells do. This breakthrough, published in Science Advances, demonstrates how microscopic bubbles, called vesicles, can be programmed to follow chemical trails. This breakthrough reveals the bare essentials needed to make synthetic life move with purpose. Decoding how vesicles navigate reveals how cells communicate and transport cargo, and provides a blueprint for engineering targeted drug delivery systems
The Institute for Bioengineering of Catalonia (IBEC) and the Catalan Health Institute (ICS) have signed a framework collaboration agreement to promote joint research, innovation and technology transfer activities in the field of bioengineering for health applications.